2002
DOI: 10.1002/jcb.10141
|View full text |Cite
|
Sign up to set email alerts
|

Signaling by the Mpl receptor involves IKK and NF‐κB*

Abstract: Binding of tumor necrosis factor-alpha (TNF-alpha) to its receptor activates IKK complex, which leads to inducement of NF-kappaB activity. Here we report that activation of Mpl ligand is also linked to IKK and NF-kappaB activity. Mpl ligand, also known as thrombopoietin (TPO) or megakaryocyte growth and development factor (MGDF), induces megakaryocyte differentiation and inhibition of mitotic proliferation, followed by induction of polyploidization and fragmentation into platelets. The latter process is often … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
24
0

Year Published

2005
2005
2016
2016

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 23 publications
(26 citation statements)
references
References 71 publications
2
24
0
Order By: Relevance
“…However, both methods indicate increased numbers of megakaryocytes, especially smaller immature forms, at day 6 in panobinostat-treated mice, followed by a return to normal megakaryocyte levels by day 19. This finding is also consistent with a model of thrombocytopenia involving temporary disruption of nuclear factor-kB signaling, as the NFkB transcription factor is important in megakaryocyte maturation, 8 and panobinostat is known to block nuclear translocation of NFkB. 6 A study by Matsuoka et al 12 also found that megakaryocyte numbers in rat spleen increase in response to the histone deacetylase inhibitor FR235225, and that inhibition of GATA-1 in megakaryocytes is associated with histone deacetylase inhibitor-induced thrombocytopenia.…”
supporting
confidence: 72%
See 1 more Smart Citation
“…However, both methods indicate increased numbers of megakaryocytes, especially smaller immature forms, at day 6 in panobinostat-treated mice, followed by a return to normal megakaryocyte levels by day 19. This finding is also consistent with a model of thrombocytopenia involving temporary disruption of nuclear factor-kB signaling, as the NFkB transcription factor is important in megakaryocyte maturation, 8 and panobinostat is known to block nuclear translocation of NFkB. 6 A study by Matsuoka et al 12 also found that megakaryocyte numbers in rat spleen increase in response to the histone deacetylase inhibitor FR235225, and that inhibition of GATA-1 in megakaryocytes is associated with histone deacetylase inhibitor-induced thrombocytopenia.…”
supporting
confidence: 72%
“…The mechanisms of bortezomib-and panobinostat-induced thrombocytopenia are not well understood, but both may involve effects on nuclear factor-kB (NFkB) nuclear translocation and downstream gene targets. [6][7][8] Here, we evaluated the kinetics of thrombocytopenia and the fate of BM megakaryocytes in panobinostat-treated mice. We hypothesized that the rate of blood platelet reduction would reflect a panobinostat-induced cessation of platelet production, rather than megakaryocyte loss, and that platelet generation by megakaryocytes would resume on discontinuation of panobinostat treatment.…”
mentioning
confidence: 99%
“…Protein was subjected to Western blot analysis (40 g/lane) as described previously (52). Immunoprecipitation experiments were pursued according to standard procedures (Santa Cruz Biotech, Santa Cruz, CA) and as described previously (53). Briefly, 500 g of soluble protein was first incubated with primary antibodies for 2 h at room temperature and further incubated overnight at 4°C after addition of 25 l of protein A/GSepharose beads (Santa Cruz Biotech, Santa Cruz, CA).…”
Section: Methodsmentioning
confidence: 99%
“…Fifty micrograms/sample of total protein was electrophoresed on 6% or 10% SDS-PAGE gels and transferred overnight at 4°C to Immobilon-P PVDF membranes (Millipore), and Western blotting was performed as described in ref. 58 …”
Section: Western Blot Analysismentioning
confidence: 99%